At 18.5% CAGR, Asia Pacific Electronic Patient-Reported Outcomes (ePROS) Market is Projected to be worth US$ 613.75 million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific electronic patient-reported outcomes (ePROS) market was valued at US$ 157.62 million in 2023 and is expected to reach US$ 613.75 million by 2031, registering a CAGR of 18.5% from 2023 to 2031. Rising adoption of telehealth & remote monitoring and increasing focus on patient-centered care are among the critical factors attributed to drive the Asia Pacific electronic patient-reported outcomes (ePROS) market growth.

The growing emphasis on patient-centered care fuels the growth of the electronic patient-reported outcomes (ePROS) market. Tools that gather patient feedback in real-time are in high demand owing to the shift toward prioritizing patient experiences, outcomes, and preferences. The real-time tracking of patient-reported health outcomes is made possible by ePROs as healthcare becomes more personalized and value-based. Better health outcomes are supported by ensuring treatments are tailored to each patient's needs. The use of digital tools such as ePROs has increased as the focus of healthcare facilities shifts to patient experience and satisfaction. With the help of this technology, patients can have less stress and receive continuous feedback by giving healthcare providers access to precise data. This change drives innovation in digital health technologies, supporting the integration of ePROs into medical procedures. For instance, healthcare providers can easily monitor patient outcomes owing to the growing integration of ePRO tools with electronic health record (EHR) systems. This facilitates the alignment of clinical decisions with the preferences and experiences that the patient has reported. Therefore, a greater understanding of patient-centered care propels the use of ePROs.

On the flip side, data privacy and security issues hamper the growth of Asia Pacific electronic patient-reported outcomes (ePROS) market.

By delivery mode, the Asia Pacific electronic patient-reported outcomes (ePROS) market is bifurcated into cloud based and on-premises. The cloud based segment held 55.6% share of Asia Pacific electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 87.62 million. It is projected to garner US$ 338.94 million by 2031 to register 18.4% CAGR during 2023–2031.

In terms of application, the Asia Pacific electronic patient-reported outcomes (ePROS) market is segmented into oncology, respiratory, and others. The oncology segment held 68.3% share of Asia Pacific electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 107.73 million. It is projected to garner US$ 429.77 million by 2031 to register 18.9% CAGR during 2023–2031.

By end user, the Asia Pacific electronic patient-reported outcomes (ePROS) market is segmented into contract research organizations (CROs), pharmaceutical companies, and others. The pharmaceutical companies segment held 56.0% share of Asia Pacific electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 88.24 million. It is projected to garner US$ 342.13 million by 2031 to register 18.5% CAGR during 2023–2031.

Based on country, the Asia Pacific electronic patient-reported outcomes (ePROS) market is categorized into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 28.3% share of Asia Pacific electronic patient-reported outcomes (ePROS) market in 2023. It was assessed at US$ 44.53 million in 2023 and is likely to hit US$ 170.44 million by 2031, registering a CAGR of 18.3% in 2023–2031.

Key players operating in the Asia Pacific electronic patient-reported outcomes (ePROS) market are Assistek, Buddy Healthcare Ltd Oy, Castor, Clinical Ink Inc, Crucial Data Solutions, Curebase, Medable Inc, Medidata Solutions, Medrio, OpenClinica LLC, PatientIQ, Signant Health, Veeva Systems Inc, and Y-Prime LLC, among others.

• August 2024, Clinical Ink launched EDCXtra, an innovative Electronic Data Capture (EDC) system. EDCXtra incorporates all existing DDC functionality into a single web-based application which includes Clinical ink’s industry leading electronic Clinical Outcome Assessments (eCOAs) and eConsent solutions, providing a comprehensive, all-in-one GCP compliant platform.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com